OQS
EBS icon

Occudo Quantitative Strategies’s Emergent Biosolutions EBS Stock Holding History

Occudo Quantitative Strategies’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-197,960
Closed -$475K – 807
2023
Q4 		$475K Buy
+197,960
New +$465K 0.06% 415
2023
Q1 		– Sell
-86,569
Closed -$1.02M – 973
2022
Q4 		$1.02M Buy
+86,569
New +$1.34M 0.12% 277
2022
Q1 		– Sell
-12,909
Closed -$561K – 1171
2021
Q4 		$561K Buy
+12,909
New +$584K 0.05% 576

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Occudo Quantitative Strategies's EBS Position: Q1 2024 in Review

Occudo Quantitative Strategies sold out of Emergent Biosolutions (EBS) in Q1 2024, closing a stake of 197,960 shares — an estimated $475K sold.

Occudo Quantitative Strategies first reported a position in EBS in Q4 2021 and held it in 3 quarters. The position peaked at $1.02M in Q4 2022. 122 funds tracked by Wall St. Rank hold EBS as of Q1 2024.

  • Occudo Quantitative Strategies reported no remaining Emergent Biosolutions position as of Q1 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 197,960 Emergent Biosolutions shares in Q1 2024, an estimated $475K.
  • Occudo Quantitative Strategies first reported a position in Emergent Biosolutions in Q4 2021 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Emergent Biosolutions position peaked at $1.02M in Q4 2022.
  • 122 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2024, filed 15 May 2024.